Test dronabinol for pain responses in people on opioid treatment
Treatments studied
Part of Pain clinical trials.
This early-stage study tests whether dronabinol (a form of THC) changes pain perception in people with opioid use disorder who are already stable on methadone or buprenorphine. It may help researchers understand whether this treatment affects pain and drug-related outcomes in a safer, controlled way.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You’re between 18 and 70 and can sign consent in English
- You have opioid use disorder and are currently stable on methadone or buprenorphine maintenance
- You’ve used cannabis/THC in the past (at least once in 10 years, or more recently at higher amounts)
- You have NOT been diagnosed with cannabis use disorder in the last 12 months
- You can do required computer/neuropsych testing and you have no serious unstable mental illness
- You’re not pregnant or breastfeeding, and you use reliable birth control (if you can become pregnant)
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether medical cannabis can help people who take opioids for long-term pain reduce their opioid use. Participants will either use medical cannabis or continue without it for 3 months.
This study tests how high potency cannabis affects mood, thinking, and pain sensitivity in people who smoke cannabis almost every day. It will help researchers understand both immediate and long-lasting effects.
This study looks at whether different types of cannabis (containing THC and/or CBD) might help people who use cannabis regularly reduce potential harms. You will be asked to take cannabis in a controlled setting and complete tasks and questionnaires.
This study tests whether a combination of THC and CBD can help people who have both opioid use disorder and chronic low back pain. You would need to be on a stable dose of methadone and have used cannabis at least once in your life.
This early study measures how a THC dose (by mouth or vaporized form) moves through the body and how it affects the body’s responses. It mainly looks at safety and how THC behaves in older adults, including people who have used cannabis before.
This trial tests whether two cannabis-based medicines, dronabinol and Epidiolex, can help ease withdrawal symptoms or cravings in people who have just started buprenorphine for opioid use disorder. It may be a good fit if you are early in treatment and still have symptoms or slip-ups.
Hear when a new Pain trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.